These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30822504)

  • 1. Mechanistic elucidation of formation of drug-rich amorphous nanodroplets by dissolution of the solid dispersion formulation.
    Ueda K; Higashi K; Moribe K
    Int J Pharm; 2019 Apr; 561():82-92. PubMed ID: 30822504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and Physicochemical Evaluation of Two Distinct Glibenclamide/Hypromellose Amorphous Nanoparticles Prepared by the Antisolvent Method.
    Yonashiro H; Higashi K; Morikawa C; Ueda K; Itoh T; Ito M; Masu H; Noguchi S; Moribe K
    Mol Pharm; 2018 Apr; 15(4):1587-1597. PubMed ID: 29502422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of Nanodroplet Formation Upon Dissolution of an Amorphous Solid Dispersion: A Mechanistic Isotope Scrambling Study.
    Indulkar AS; Waters JE; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    J Pharm Sci; 2017 Aug; 106(8):1998-2008. PubMed ID: 28431965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction Times.
    Wilson VR; Mugheirbi NA; Mosquera-Giraldo LI; Deac A; Moseson DE; Smith DT; Novo DC; Borca CH; Slipchenko LV; Edgar KJ; Taylor LS
    Mol Pharm; 2021 Mar; 18(3):836-849. PubMed ID: 33539105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Drug-Polymer Interactions through Hypromellose Acetate Succinate Substituents on the Physical Stability on Solid Dispersions Studied by Fourier-Transform Infrared and Solid-State Nuclear Magnetic Resonance.
    Ishizuka Y; Ueda K; Okada H; Takeda J; Karashima M; Yazawa K; Higashi K; Kawakami K; Ikeda Y; Moribe K
    Mol Pharm; 2019 Jun; 16(6):2785-2794. PubMed ID: 31045376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways.
    Edueng K; Mahlin D; Larsson P; Bergström CAS
    J Control Release; 2017 Jun; 256():193-202. PubMed ID: 28412224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mobility Suppression of Ibuprofen-Rich Amorphous Nanodroplets by HPMC Revealed by NMR Relaxometry and Its Significance with Respect to Crystallization Inhibition.
    Ueda K; Yamamoto N; Higashi K; Moribe K
    Mol Pharm; 2019 Dec; 16(12):4968-4977. PubMed ID: 31661287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between drug dissolution and resistance to water-induced phase separation in solid dispersion formulations revealed by solid-state NMR spectroscopy.
    Okada H; Ueda K; Yasuda Y; Higashi K; Inoue M; Ito M; Noguchi S; Kawakami K; Moribe K
    Int J Pharm; 2020 Mar; 577():119086. PubMed ID: 31991185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergetic Role of Hypromellose and Methacrylic Acid Copolymer in the Dissolution Improvement of Amorphous Solid Dispersions.
    Ohyagi N; Ueda K; Higashi K; Yamamoto K; Kawakami K; Moribe K
    J Pharm Sci; 2017 Apr; 106(4):1042-1050. PubMed ID: 27988162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of drug and EUDRAGIT® S 100 miscibility in solid dispersions on the drug and polymer dissolution rate.
    Higashi K; Hayashi H; Yamamoto K; Moribe K
    Int J Pharm; 2015 Oct; 494(1):9-16. PubMed ID: 26253374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
    Xie T; Gao W; Taylor LS
    Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
    Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
    Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR technique.
    Ueda K; Higashi K; Yamamoto K; Moribe K
    Mol Pharm; 2015 Apr; 12(4):1096-104. PubMed ID: 25723893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation mechanism of amorphous drug nanoparticles using the antisolvent precipitation method elucidated by varying the preparation temperature.
    Morikawa C; Ueda K; Omori M; Higashi K; Moribe K
    Int J Pharm; 2021 Dec; 610():121210. PubMed ID: 34687818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
    Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
    Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Investigation of Intestinal Drug Absorption Enhancement by Drug-Rich Nanodroplets Generated via Liquid-Liquid Phase Separation.
    Yoshikawa E; Ueda K; Hakata R; Higashi K; Moribe K
    Mol Pharm; 2024 Apr; 21(4):1745-1755. PubMed ID: 38501717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.